Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

Objective To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage. Design Pooled analysis of two multicentre, phase three masked randomised controlled trials Setting Multicentre trials in several continents and in Costa Rica. Participants 26 130 women aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Wacholder, Sholom, Chen, Bingshu Eric, Wilcox, Allen, Macones, George, Gonzalez, Paula, Befano, Brian, Hildesheim, Allan, Rodríguez, Ana Cecilia, Solomon, Diane, Herrero, Rolando, Schiffman, Mark
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831171/
https://www.ncbi.nlm.nih.gov/pubmed/20197322
http://dx.doi.org/10.1136/bmj.c712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831171/
https://www.ncbi.nlm.nih.gov/pubmed/20197322
http://dx.doi.org/10.1136/bmj.c712

Ejemplares similares